Headlines

From informed to involved: Qina shares shifts in personalised nutrition space

Mariette Abrahams, CEO and founder of Qina, discusses how consumers are now seeking support to action personalised advice, urging personalised nutrition (PN) platforms to prioritise behavioural change approaches and incorporate technology and wearables to achieve this.

Synbiotics for stress: study observes reduced markers of inflammation

The new study finds that those suffering with Fibromyalgia (FM) administered the synbiotic showed a significant reduction in the inflammatory marker IL-8, as well as perceived stress and anxiety levels.

Content provided by ADM

BLP1™ Probiotic and Postbiotic Support for Metabolic Health

Support for metabolic health is a growing area for product development. Here’s why you should consider formulating weight management products with pro- and postbiotics.

Pilot study suggests vitamin K2 supplement surpasses diet in ability to reduce deficiency

A pilot study involving 12 patients with chronic kidney disease suggests supplementation surpasses a vitamin-rich diet in improving vit K levels in individuals who are susceptible to deficiency.

Calanus oil matches krill and fish oil for Omega-3 Index boosts: Study

Calanus oil may be equally as effective at increasing the Omega-3 Index as fish oil and krill oil, says a new study that supports the copepod-derived oil as an alternative marine omega-3 source.

Content provided by PharmaNutra Spa

Study highlights a key aid for the management of tendinopathies

Tendinitis and tendinosis share a common and painful symptomatology often known as tendinopathy. A clinical study indicates the use of a patch can improve function and reduce symptoms of pain in certain cases of tendinopathy, promoting recovery.

Nicotinamide mononucleotide (NMN) is increasingly studied in recent years for its potential health benefits. ©Getty Images

NMN and arterial stiffness: Individuals with above-average BMI or blood glucose could benefit – Japan DHC Corp study

Individuals who have above-average body mass index or blood glucose levels have seen a reduction in arterial stiffness following 12 weeks of nicotinamide mononucleotide (NMN) supplementation.